NASDAQ: SMTI - Sanara MedTech Inc.

Rentabilidad a seis meses: -4.88%
Sector: Healthcare

Calendario de promoción Sanara MedTech Inc.


Acerca de la empresa

Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States.

Más detalles
It also offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. The company provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

Выручка 0.0118
EBITDA -0.0025
Число акций ао 0.00828 млрд
P/S 3.07
P/BV 5.66
EV/EBITDA -12.66
Цена ао 36.75
ISIN US79957L1008
Сайт https://sanaramedtech.com
Валюта usd
IPO date 2011-02-22
Sector Health Care
Industry Health Care Equipment & Supplies
Валюта отчета usd
Cambio de precio por día: 0% (32.14)
Cambio de precio por semana.: +0.187% (32.08)
Cambio de precio por mes: -6.79% (34.48)
Cambio de precio en 3 meses.: +10.45% (29.1)
Cambio de precio en seis meses: -4.88% (33.79)
Cambio de precio por año: +9.51% (29.35)
Cambio de precio en 3 años.: -4% (33.48)
Cambio de precio en 5 años.: +322.89% (7.6)
Cambio de precio desde principios de año.: -0.8637% (32.42)

Subestimación

Nombre Significado Calificación
P/S 4.88 3
P/BV 7.11 1
P/E 0 0
EV/EBITDA -81.07 0
Total: 2.25

Eficiencia

Nombre Significado Calificación
ROA, % -5.83 0
ROE, % -9.6 0
Total: 0

Dividendos

Nombre Significado Calificación
Div yield, % 0 0
DSI 0 0
Total: 0.2329

Deber

Nombre Significado Calificación
Debt/EBITDA -2.52 10
Total: 8

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 450.76 10
Rentabilidad Ebitda, % 59.6 7
Rentabilidad EPS, % -36.66 0
Total: 4.6

ETF Compartir, % Rentabilidad del año, % Dividendos, %
WisdomTree U.S. SmallCap Fund 0.01751 29.467482438251 1.80258
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.02292 31.359936575053 1.41955
ProShares Hedge Replication ETF 0.00077 5.9237999659878 1.47892
iShares Micro-Cap ETF 0.03246 34.327031588619 1.54048
iShares Russell 2000 Growth ETF 0.00951 38.042556988 0.6026
ProShares UltraPro Russell2000 0.00277 89.821266282945 1.47873
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0.01 37.361289927043 0.60264
Vanguard Russell 2000 ETF 0.01 32.773459189339 1.48801



Supervisor Título profesional Pago año de nacimiento
Mr. Ronald T. Nixon Executive Chairman & CEO N/A 1956 (68 años)
Mr. Michael D. McNeil CFO & Corporate Secretary 438.68k 1965 (59 años)
Dr. Christopher A. Morrison FACHM, FAPWCA, FCCWS, M.D. President of Telehealth Services 156k 1970 (54 año)
Mr. Callon Nichols Vice President of Corporate Operations N/A
Mr. Bill Fitzgerald Chief Compliance Officer N/A
Ms. Tricia Matteson Vice President of Marketing N/A
Dr. Rebecca Erin Mcmahon President of Research & Development N/A 1985 (39 años)
Mr. Seth Yon President of Commercial N/A
Mr. Jacob A. Waldrop Chief Operating Officer
Mr. Tyler Palmer Chief Corporate Development & Strategy Officer

DIRECCIÓN: United States, Fort Worth. TX, 1200 Summit Avenue - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://sanaramedtech.com